SPMGX
Price
$8.92
Change
-$0.11 (-1.22%)
Updated
Jan 22 closing price
Net Assets
1.11B
SPMHX
Price
$9.28
Change
-$0.11 (-1.17%)
Updated
Jan 22 closing price
Net Assets
1.11B
Ad is loading...

SPMGX vs SPMHX

Header iconSPMGX vs SPMHX Comparison
Open Charts SPMGX vs SPMHXBanner chart's image
Invesco SteelPath MLP Alpha R
Price$8.92
Change-$0.11 (-1.22%)
VolumeN/A
Net Assets1.11B
Invesco SteelPath MLP Alpha R5
Price$9.28
Change-$0.11 (-1.17%)
VolumeN/A
Net Assets1.11B
SPMGX vs SPMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SPMGX vs. SPMHX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPMGX is a Buy and SPMHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SPMGX (1.11B) and SPMHX (1.11B) have equal amount of cash in the bank . SPMGX (5.29) and SPMHX (5.12) have matching dividends . SPMGX was incepted earlier than SPMHX: SPMGX (6 years) vs SPMHX (6 years). SPMGX (32.00) and SPMHX (32.00) have comparable annual turnover. SPMGX has a lower initial minimum investment than SPMHX: SPMGX (1000) vs SPMHX (1000000). SPMHX (51.09) and SPMGX (50.30) have marching annual gain over last year. SPMHX (143.04) and SPMGX (136.85) have equivalent 5 years return.
SPMGXSPMHXSPMGX / SPMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years6 years-
Gain YTD7.3067.258101%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B1.11B100%
Annual Yield % from dividends5.295.12103%
Returns for 1 year50.3051.0998%
Returns for 3 years118.78122.1597%
Returns for 5 years136.85143.0496%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOCO15.061.32
+9.61%
GoHealth
FN252.1010.21
+4.22%
Fabrinet
SXI194.163.53
+1.85%
Standex International Corp
EQBK43.760.63
+1.46%
Equity Bancshares
DRMA1.27-0.06
-4.51%
Dermata Therapeutics Inc.